Cargando…
Sanguisorba officinalis L. suppresses non-small cell lung cancer via downregulating the PI3K/AKT/mTOR signaling pathway based on network pharmacology and experimental investigation
Background: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Sanguisorba officinalis L. (SOL), a traditional Chinese herbal medicine called Diyu, has been shown to have potent antitumor effects. However, the role of SOL in suppressing NSCLC remains unknown. Methods: Network...
Autores principales: | Li, Hong, Lin, Jing, Yang, Fei, Deng, Junzhu, Lai, Jia, Zeng, Jing, Zou, Wenjun, Jiang, Nan, Huang, Qianqian, Li, Hua, Liu, Jian, Li, Mao, Zhong, Zhirong, Wu, Jianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729289/ https://www.ncbi.nlm.nih.gov/pubmed/36506573 http://dx.doi.org/10.3389/fphar.2022.1054803 |
Ejemplares similares
-
Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the Sanguisorba Officinalis in Suppressing Hepatocellular Carcinoma
por: Jiang, Nan, et al.
Publicado: (2021) -
Antitumor Effects of Trimethylellagic Acid Isolated From Sanguisorba officinalis L. on Colorectal Cancer via Angiogenesis Inhibition and Apoptosis Induction
por: Bai, Chongfei, et al.
Publicado: (2020) -
TMEA, a Polyphenol in Sanguisorba officinalis, Promotes Thrombocytopoiesis by Upregulating PI3K/Akt Signaling
por: Li, Hong, et al.
Publicado: (2021) -
Rapid Profiling of Metabolites Combined with Network Pharmacology to Explore the Potential Mechanism of Sanguisorba officinalis L. against Thrombocytopenia
por: Dai, Yubei, et al.
Publicado: (2022) -
A Comprehensive Review of Genus Sanguisorba: Traditional Uses, Chemical Constituents and Medical Applications
por: Zhou, Ping, et al.
Publicado: (2021)